Literature DB >> 27301863

Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.

Patrick M Brauer1, Itai M Pessach2, Erik Clarke3, Jared H Rowe4, Lisa Ott de Bruin4, Yu Nee Lee4, Carmen Dominguez-Brauer5, Anne M Comeau6, Geneve Awong7, Kerstin Felgentreff4, Yuhang H Zhang8, Andrea Bredemeyer9, Waleed Al-Herz10, Likun Du4, Francesca Ververs4, Marion Kennedy11, Silvia Giliani12, Gordon Keller11, Barry P Sleckman9, David G Schatz13, Frederic D Bushman3, Luigi D Notarangelo14, Juan Carlos Zúñiga-Pflücker1.   

Abstract

Primary immunodeficiency diseases comprise a group of heterogeneous genetic defects that affect immune system development and/or function. Here we use in vitro differentiation of human induced pluripotent stem cells (iPSCs) generated from patients with different recombination-activating gene 1 (RAG1) mutations to assess T-cell development and T-cell receptor (TCR) V(D)J recombination. RAG1-mutants from severe combined immunodeficient (SCID) patient cells showed a failure to sustain progression beyond the CD3(--)CD4(-)CD8(-)CD7(+)CD5(+)CD38(-)CD31(-/lo)CD45RA(+) stage of T-cell development to reach the CD3(-/+)CD4(+)CD8(+)CD7(+)CD5(+)CD38(+)CD31(+)CD45RA(-) stage. Despite residual mutant RAG1 recombination activity from an Omenn syndrome (OS) patient, similar impaired T-cell differentiation was observed, due to increased single-strand DNA breaks that likely occur due to heterodimers consisting of both an N-terminal truncated and a catalytically dead RAG1. Furthermore, deep-sequencing analysis of TCR-β (TRB) and TCR-α (TRA) rearrangements of CD3(-)CD4(+)CD8(-) immature single-positive and CD3(+)CD4(+)CD8(+) double-positive cells showed severe restriction of repertoire diversity with preferential usage of few Variable, Diversity, and Joining genes, and skewed length distribution of the TRB and TRA complementary determining region 3 sequences from SCID and OS iPSC-derived cells, whereas control iPSCs yielded T-cell progenitors with a broadly diversified repertoire. Finally, no TRA/δ excision circles (TRECs), a marker of TRA/δ locus rearrangements, were detected in SCID and OS-derived T-lineage cells, consistent with a pre-TCR block in T-cell development. This study compares human T-cell development of SCID vs OS patients, and elucidates important differences that help to explain the wide range of immunologic phenotypes that result from different mutations within the same gene of various patients.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27301863      PMCID: PMC4982452          DOI: 10.1182/blood-2015-10-676304

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

Review 1.  The mechanism and regulation of chromosomal V(D)J recombination.

Authors:  Craig H Bassing; Wojciech Swat; Frederick W Alt
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.

Authors:  Xiaomin Yu; Jorge R Almeida; Sam Darko; Mirjam van der Burg; Suk See DeRavin; Harry Malech; Andrew Gennery; Ivan Chinn; Mary Louise Markert; Daniel C Douek; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2014-01-07       Impact factor: 10.793

Review 3.  The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases.

Authors:  Joshua D Milner; Steven M Holland
Journal:  Nat Rev Immunol       Date:  2013-07-26       Impact factor: 53.106

4.  Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs.

Authors:  Tushar Menon; Amy L Firth; Deirdre D Scripture-Adams; Zoran Galic; Susan J Qualls; William B Gilmore; Eugene Ke; Oded Singer; Leif S Anderson; Alexander R Bornzin; Ian E Alexander; Jerome A Zack; Inder M Verma
Journal:  Cell Stem Cell       Date:  2015-03-12       Impact factor: 24.633

5.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model.

Authors:  Khie Khiong; Masaaki Murakami; Chika Kitabayashi; Naoko Ueda; Shin-ichiro Sawa; Akemi Sakamoto; Brian L Kotzin; Stephen J Rozzo; Katsuhiko Ishihara; Marileila Verella-Garcia; John Kappler; Philippa Marrack; Toshio Hirano
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 6.  The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.

Authors:  Katja G Weinacht; Patrick M Brauer; Kerstin Felgentreff; Alex Devine; Andrew R Gennery; Silvia Giliani; Waleed Al-Herz; Axel Schambach; Juan Carlos Zúñiga-Pflücker; Luigi D Notarangelo
Journal:  Curr Opin Immunol       Date:  2012-07-25       Impact factor: 7.486

7.  Development of TCRB CDR3 length repertoire of human T lymphocytes.

Authors:  Junko Nishio; Mihoko Suzuki; Toshihiro Nanki; Nobuyuki Miyasaka; Hitoshi Kohsaka
Journal:  Int Immunol       Date:  2004-03       Impact factor: 4.823

Review 8.  Molecular pathology of severe combined immunodeficiency in mice, horses, and dogs.

Authors:  L E Perryman
Journal:  Vet Pathol       Date:  2004-03       Impact factor: 2.221

9.  Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells.

Authors:  O Ostling; K J Johanson
Journal:  Biochem Biophys Res Commun       Date:  1984-08-30       Impact factor: 3.575

10.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.

Authors:  T Blunt; N J Finnie; G E Taccioli; G C Smith; J Demengeot; T M Gottlieb; R Mizuta; A J Varghese; F W Alt; P A Jeggo; S P Jackson
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

View more
  17 in total

Review 1.  Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy.

Authors:  Huang Zhu; Yi-Shin Lai; Ye Li; Robert H Blum; Dan S Kaufman
Journal:  Stem Cells       Date:  2018-01-03       Impact factor: 6.277

Review 2.  T Cell Genesis: In Vitro Veritas Est?

Authors:  Patrick M Brauer; Jastaranpreet Singh; Sintia Xhiku; Juan Carlos Zúñiga-Pflücker
Journal:  Trends Immunol       Date:  2016-10-24       Impact factor: 16.687

Review 3.  Stem cell-based multi-tissue platforms to model human autoimmune diabetes.

Authors:  Karla F Leavens; Juan R Alvarez-Dominguez; Linda T Vo; Holger A Russ; Audrey V Parent
Journal:  Mol Metab       Date:  2022-10-06       Impact factor: 8.568

4.  Generation and Hematopoietic Differentiation of Mesenchymal Stromal/Stem Cell-Derived Induced Pluripotent Stem Cell Lines for Disease Modeling of Hematopoietic and Immunological Diseases.

Authors:  Gülen Güney-Esken; Fatima Aerts-Kaya
Journal:  Methods Mol Biol       Date:  2022

5.  Cutting Edge: TCR-β Selection Is Required at the CD4+CD8+ Stage of Human T Cell Development.

Authors:  Edward L Y Chen; Patrick M Brauer; Elisa C Martinez; Xiaotian Huang; Ning Yu; Michele K Anderson; Yang Li; Juan Carlos Zúñiga-Pflücker
Journal:  J Immunol       Date:  2021-05-03       Impact factor: 5.422

6.  Gene Editing Rescues In vitro T Cell Development of RAG2-Deficient Induced Pluripotent Stem Cells in an Artificial Thymic Organoid System.

Authors:  Cameron L Gardner; Mara Pavel-Dinu; Kerry Dobbs; Marita Bosticardo; Paul K Reardon; Justin Lack; Suk See DeRavin; Kent Le; Ezekiel Bello; Francesca Pala; Ottavia M Delmonte; Harry Malech; Amelie Montel-Hagan; Gay Crooks; Oreste Acuto; Matthew H Porteus; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2021-03-01       Impact factor: 8.542

7.  Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency.

Authors:  Panojot Bifsha; Jennifer W Leiding; Sung-Yun Pai; Aurelien B L Colamartino; Nicholas Hartog; Joseph A Church; Benjamin R Oshrine; Jennifer M Puck; M Louise Markert; Elie Haddad
Journal:  Blood Adv       Date:  2020-06-23

8.  Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia.

Authors:  Marita Bosticardo; Francesca Pala; Enrica Calzoni; Ottavia M Delmonte; Kerry Dobbs; Cameron L Gardner; Nicolo' Sacchetti; Tomoki Kawai; Elizabeth K Garabedian; Debbie Draper; Jenna R E Bergerson; Suk See DeRavin; Alexandra F Freeman; Tayfun Güngör; Nicholas Hartog; Steven M Holland; Donald B Kohn; Harry L Malech; Mary Louise Markert; Katja G Weinacht; Anna Villa; Christopher S Seet; Amelie Montel-Hagen; Gay M Crooks; Luigi D Notarangelo
Journal:  Blood Adv       Date:  2020-06-23

9.  EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay.

Authors:  Stefano Volpi; Yasuhiro Yamazaki; Patrick M Brauer; Ellen van Rooijen; Atsuko Hayashida; Anne Slavotinek; Hye Sun Kuehn; Maja Di Rocco; Carlo Rivolta; Ileana Bortolomai; Likun Du; Kerstin Felgentreff; Lisa Ott de Bruin; Kazutaka Hayashida; George Freedman; Genni Enza Marcovecchio; Kelly Capuder; Prisni Rath; Nicole Luche; Elliott J Hagedorn; Antonella Buoncompagni; Beryl Royer-Bertrand; Silvia Giliani; Pietro Luigi Poliani; Luisa Imberti; Kerry Dobbs; Fabienne E Poulain; Alberto Martini; John Manis; Robert J Linhardt; Marita Bosticardo; Sergio Damian Rosenzweig; Hane Lee; Jennifer M Puck; Juan Carlos Zúñiga-Pflücker; Leonard Zon; Pyong Woo Park; Andrea Superti-Furga; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2017-02-01       Impact factor: 14.307

Review 10.  Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders.

Authors:  Methichit Wattanapanitch
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.